Condition (MeSH)
Alcohol-Induced Disorders, Nervous System
ClinicalTrials.gov lists 16 trials for Alcohol-Induced Disorders, Nervous System or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 16 trials are tagged with Alcohol-Induced Disorders, Nervous System itself; the rest are tagged with a narrower condition beneath it.
When did Alcohol-Induced Disorders, Nervous System trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2012 | 4 |
| 2010 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Alcohol-Induced Disorders, Nervous System trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 3 |
| Not applicable | 6 |
| Observational | 3 |
How many Alcohol-Induced Disorders, Nervous System trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Completed | 9 |
| Terminated | 2 |
| Withdrawn | 2 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Alcohol-Induced Disorders, Nervous System? (4)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Lorazepam | 2 |
| Phenobarbital | 2 |
| Pitolisant | 1 |
| DEXMEDETOMIDINE | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| baclofen 2% | 2 |
| IM Oxytocin | 1 |
| BZDP-Based Protocol | 1 |
| Levetiracetam XR | 1 |
| Dexmedetomidine 0.004 MG/ML | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Alcohol-Induced Disorders, Nervous System trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Rapid progression of complications of alcoholism | 3 | 1 |
| Respiratory failure | 3 | 1 |
| Septic shock | 2 | 1 |
| Acute kidney injury | 1 | 1 |
| Aspiration | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Alcohol-Induced Disorders, Nervous System? (14)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. | The Journal of emergency medicine | 2013 | Yes |
| Adolescent brain development and underage drinking in the United States: identifying risks of alcohol use in college populations. | Harvard review of psychiatry | 2012 | Yes |
| Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2012 | Yes |
| Dihydromyricetin as a novel anti-alcohol intoxication medication. | The Journal of neuroscience : the official journal of the Society for Neuroscience | 2012 | Yes |
| Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence. | Alcohol (Fayetteville, N.Y.) | 2010 | Yes |
Showing 5 of 14 publications.
Sub-conditions in MeSH (4)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, and rare-disease identity.